ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Infectious Disease

Top Infectious Disease Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALBERT ANDERSON M.D.

Infectious Disease

6,979

$2.82M

362
27 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 49%

$404
Average prescription price

Avg: $438

MELODY PALMORE M.D.

Infectious Disease

5,270

$2.15M

350
30 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 49%

$407
Average prescription price

Avg: $438

MOBOLAJI OGUNSAKIN M.D.

Infectious Disease

4,968

$499K

203
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 49%

$100
Average prescription price

Avg: $438

CLIFFORD GUNTHEL M.D.

Infectious Disease

4,721

$2.02M

239
15 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 49%

$427
Average prescription price

Avg: $438

HAROLD KATNER MD

Infectious Disease

4,720

$2.82M

288
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 49%

$598
Average prescription price

Avg: $438

JOHN OUDERKIRK M.D.

Infectious Disease

4,509

$2.34M

170
35 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 49%

$520
Average prescription price

Avg: $438

MINH NGUYEN MD

Infectious Disease

4,390

$1.82M

245
22 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 49%

$414
Average prescription price

Avg: $438

ELLIOT RAIZES MD

Infectious Disease

4,368

$2.74M

219
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 49%

$627
Average prescription price

Avg: $438

CHERYL NEWMAN MD

Infectious Disease

4,226

$2.12M

143
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 49%

$501
Average prescription price

Avg: $438

DANNY BRANSTETTER M.D.

Infectious Disease

4,167

$1.69M

242
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 49%

$405
Average prescription price

Avg: $438

FOLARIN OLUBOWALE MD

Infectious Disease

4,159

$1.3M

277
119 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 49%

$311
Average prescription price

Avg: $438

JEFFREY STEPHENS MD

Infectious Disease

3,716

$1.91M

277
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 49%

$513
Average prescription price

Avg: $438

GUILLERMO SAURINA

Infectious Disease

3,572

$601K

282
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 49%

$168
Average prescription price

Avg: $438

TARAK PATEL M.D.

Infectious Disease

3,487

$2.52M

311
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 49%

$724
Average prescription price

Avg: $438

AFRICA ALVAREZ M.D.

Infectious Disease

2,917

$1.49M

92
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 49%

$510
Average prescription price

Avg: $438

MARIANNE LAGUERRE M.D.

Infectious Disease

2,884

$233K

197
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 49%

$81
Average prescription price

Avg: $438

MOLLY EATON MD

Infectious Disease

2,856

$1.33M

132
22 are 65+

15%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 49%

$465
Average prescription price

Avg: $438

THOMAS SHEFTEL MD

Infectious Disease

2,763

$538K

271
191 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 49%

$195
Average prescription price

Avg: $438

HAROLD STRINGER MD

Infectious Disease

2,562

$1.01M

78
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 49%

$395
Average prescription price

Avg: $438

DAVID HABURCHAK MD

Infectious Disease

2,513

$1.31M

102
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 49%

$521
Average prescription price

Avg: $438

RICHARD PROKESCH M.D.

Infectious Disease

2,333

$1.14M

133
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 49%

$487
Average prescription price

Avg: $438

KIMBERLY WORKOWSKI M.D.

Infectious Disease

2,266

$1.28M

104
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 49%

$567
Average prescription price

Avg: $438

DENNIS MELTON M.D.

Infectious Disease

2,257

$1.1M

142
35 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 49%

$485
Average prescription price

Avg: $438

RITU KUMAR MD

Infectious Disease

2,213

$1.3M

179
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 49%

$586
Average prescription price

Avg: $438

LEE DIAMOND M.D.

Infectious Disease

1,924

$1M

149
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 49%

$521
Average prescription price

Avg: $438

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank